Previous close | 555.12 |
Open | 556.27 |
Bid | 525.78 x 800 |
Ask | 0.00 x 900 |
Day's range | 556.13 - 560.49 |
52-week range | 373.28 - 566.01 |
Volume | |
Avg. volume | 675,550 |
Market cap | 72.78B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 25.00 |
EPS (TTM) | 22.40 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 2.48 (0.44%) |
Ex-dividend date | 03 Jun 2024 |
1y target est | 595.69 |
Investors in McKesson Corporation ( NYSE:MCK ) had a good week, as its shares rose 2.4% to close at US$544 following...
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript May 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $6.18 EPS, expectations were $6.36. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Please stand by. Welcome to […]